# Effect of Benoxinate Hydrochloride Eye Drops on The Premature Infant Pain Profile Score During Retinopathy of Prematurity Screening

> **NCT06461975** · PHASE3 · COMPLETED · sponsor: **Alexandria University** · enrollment: 88 (actual)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Benoxinate Hydrochloride
- **DRUG:** artificial tear (Sodium Hyaluronate 2 mg/ml) eye drops.

## Key facts

- **NCT ID:** NCT06461975
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-06-01
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2024-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06461975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06461975, "Effect of Benoxinate Hydrochloride Eye Drops on The Premature Infant Pain Profile Score During Retinopathy of Prematurity Screening". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06461975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*